Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients

NCT04218435 is registered in ClinicalTrials.gov with Clinision as lead sponsor.

NCT NCT04218435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04218435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients
Lead sponsor
Clinision
Phase
Observational
Overall status
Completed
Start date
January 1, 2019
Completion date
December 30, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure nyha class ii, heart failure nyha class iv